Cambridge Nutritional Sciences (CNSL) Competitors

Cambridge Nutritional Sciences (LON:CNSL) and Celadon Pharmaceuticals (LON:CEL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

Is CNSL or CEL more profitable?

Cambridge Nutritional Sciences has a net margin of -3.36% compared to Celadon Pharmaceuticals' net margin of -4,024.62%. Cambridge Nutritional Sciences' return on equity of -3.34% beat Celadon Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cambridge Nutritional Sciences	-3.36%	-3.34%	-2.36%
Celadon Pharmaceuticals	-4,024.62%	-187.26%	-34.40%

Which has better earnings and valuation, CNSL or CEL?

Cambridge Nutritional Sciences has higher revenue and earnings than Celadon Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cambridge Nutritional Sciences	£9.77M	0.80	-£3.03M	N/A	N/A
Celadon Pharmaceuticals	£123.38K	73.07	-£4.97M	-£7.98	-1.84

Does the MarketBeat Community prefer CNSL or CEL?

Celadon Pharmaceuticals received 4 more outperform votes than Cambridge Nutritional Sciences when rated by MarketBeat users.

Company	Underperform	Outperform
Cambridge Nutritional Sciences	N/A	N/A
Celadon Pharmaceuticals	Outperform Votes 4 100.00%	Underperform Votes No Votes

Do insiders & institutionals believe in CNSL or CEL?

10.2% of Cambridge Nutritional Sciences shares are held by institutional investors. Comparatively, 10.7% of Celadon Pharmaceuticals shares are held by institutional investors. 10.9% of Cambridge Nutritional Sciences shares are held by company insiders. Comparatively, 65.1% of Celadon Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Which has more volatility and risk, CNSL or CEL?

Cambridge Nutritional Sciences has a beta of 3.89, suggesting that its stock price is 289% more volatile than the S&P 500. Comparatively, Celadon Pharmaceuticals has a beta of -0.26, suggesting that its stock price is 126% less volatile than the S&P 500.

Does the media favor CNSL or CEL?

In the previous week, Celadon Pharmaceuticals had 2 more articles in the media than Cambridge Nutritional Sciences. MarketBeat recorded 2 mentions for Celadon Pharmaceuticals and 0 mentions for Cambridge Nutritional Sciences. Cambridge Nutritional Sciences' average media sentiment score of 0.00 beat Celadon Pharmaceuticals' score of -0.26 indicating that Cambridge Nutritional Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
Cambridge Nutritional Sciences	Neutral
Celadon Pharmaceuticals	Neutral

Summary

Cambridge Nutritional Sciences beats Celadon Pharmaceuticals on 7 of the 13 factors compared between the two stocks.